PMA device
Algovita Spinal Cord Stimulation System
Nuvectra Corporation · Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW, Class III) · First FDA decision Nov 20, 2015, newest May 5, 2020Chronic pain
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
5
Naming "Algovita"
MAUDE reports
193
Brand "Algovita", since 2015
PubMed studies
1
Mentioning "Algovita"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Algovita Spinal Cord Stimulation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Algovita Spinal Cord Stimulation SystemPMA supplement
P130028-S031 · Decided May 5, 2020 · 182 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- Algovita Spinal Cord Stimulation SystemPMA supplement
P130028-S025 · Decided Dec 31, 2019 · 207 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
- Algovita Spinal Cord Stimulation SystemPMA supplement
P130028-S018 · Decided Nov 28, 2018 · 534 days after receipt · Normal 180 Day Track
Device type: Stimulator, spinal-cord, totally implanted for pain relief (LGW) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Algovita", any status and sponsor, newest update first.
The Cleveland ClinicAcademic, hospital or other
NCT03794024 · 1 participants · Start Jan 8, 2019 · Primary completion Mar 3, 2020
Device: The Nuvectra Algovita Dorsal Column Spinal Cord Stimulator; The Axium Neurostimulator System · For: Complex Regional Pain Syndrome
Sites: Cleveland, Ohio
NuvectraNot on our public-company list
NCT03622866 · 20 participants · Start Nov 2, 2018 · Primary completion Apr 27, 2020
Device: Ultra-high pulse width stimulation; Traditional pulse width stimulation · For: Chronic Pain
Sites: Tucson, Arizona; Newport Beach, California; Santa Rosa, California · 10 sites in all
Kettering Health NetworkAcademic, hospital or other
NCT03756012 · 15 participants · Start Nov 27, 2018 · Primary completion Oct 2, 2019
Device: Algovita Spinal Cord Stimulation System · For: Back Pain; Pain
Sites: Centerville, Ohio
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Algovita", and for the whole product code for context.
This brand
193 reports: 60 malfunction, 129 injury, 4 death
Whole product code LGW
301,867 reports: 79,174 malfunction, 220,939 injury, 1,642 death
Newest reports for this brand
MW5155130 · Received May 17, 2024
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF)
Patient problem as coded: Failure of Implant; Inadequate Pain Relief
- ALGOVITA SPINAL CORD STIMULATION SYSTEMMalfunction
MW5147571 · Received Oct 31, 2023
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Break; Material Frayed; Difficult to Remove; Use of Device Problem
Patient problem as coded: Failure of Implant
- SCS ALGOVITAMalfunction
MW5142071 · Received Aug 12, 2023
Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Device problem as coded: Failure to Charge; Overheating of Device
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0781-2017 · Started Oct 11, 2016 · Posted by FDA Dec 17, 2016
Reason given: Nuvectra is conducting a recall due to two clinical risks that are associated with certain percutaneous leads currently being used in the Algovita Spinal Cord Stimulation System. It has been reported that in some percutaneous leads, the stylet protruded beyond the distal lead tip.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-1600-2016 · Started Apr 6, 2016 · Posted by FDA May 3, 2016
Reason given: If used, the optional Swap feature copies programming parameters from the external pulse generator (EPG) as well as unintended calibration data to the implantable pulse generator (lPG). This may result in the user being unable to recharge the lPG. This safety notice only applies to CPs Model 4500.
Cause as FDA categorized it: Software design · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
Z-1192-2016 · Started Jan 26, 2016 · Posted by FDA Mar 18, 2016
Reason given: The implantable pulse generator (IPG) model 2408 had suboptimal performance establishing a connection to the external devices unless they were brought into close proximity (as close as 5 cm). The following functions may not be available: Reprogramming the stimulator, Adjusting stimulation parameters (on/off, intensity...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Stimulator, Spinal-Cord, Totally Implanted For Pain Relief (LGW)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Algovita"[tiab]. The summary above synthesizes these.
- Neuromodulation Systems in the Setting of Cochlear Implant Treatment Based on Case Reports and Literature Review.
Weise F, Schaumann K, Volpert S, et al. · Neuromodulation · 2025Case Reports, Review
Other devices of this type
Also filed under product code LGW.
- Precision Spinal Cord Stimulator (SCS) SystemsBoston Scientific Corp · PMA 2026
- Senza Spinal Cord Stimulation (SCS) SystemNevro Corporation · PMA 2025
- Saluda Medical Evoke SCS SystemSaluda Medical Pty, Ltd. · PMA 2026
- Master RestoreMedtronic Neuromodulation · PMA 2026
- RestoreMedtronic Neuromodulation · PMA 2025
- Genesis and Eon Family Neurostimulation (Ipg) SystemsAbbott Medical · PMA 2016
- Genesis Neurostimulation SystemAbbott Medical · PMA 2024
- Precision Spectra Spinal Cord Stimulator (SCS) SystemBoston Scientific Corp · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.